Resources: Overview

Publications

Miller I, Ashton-Chess J, Spolders H, Fert V, Ferrara J, Kroll W, Askaa J, Larcier P, Terry PF, Bruinvels A, & Huriez A (March 2011). Market Access Challenges in the EU for High Medical Value Diagnostic Tests. Future Medicine: Journal of Personalized Medicine. 8(2):137-148.

Parker D (December 2010). The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics. Personalized Medicine Coalition (PMC). Issue Brief.

Chan S, Slawsky K, Prottas C, Feldmann J, & Goss T (March 2010). Recognizing Value in Oncology Innovation. White Paper.

Mathews C, Geldart T, & McInnis M (2009, August 31). Improving Healthcare Through Diagnostics: The Future of IVDs. Clinica Diagnostics. 50, 1-5.

Mathews C (2009, July 6). Cost-Savings or Value Capture: IVD Industry at a Crossroads. Clinica Diagnostics. 46, 1-5.

See more publications

Case Studies

• Pre-Launch Market Analytics for a Specialty Pharmaceutical
• Reimbursement Assessment for Product Launch
• Reimbursement Strategy for Novel Breast Cancer Test
• IVD Business Development Strategy
• Implementation Strategy to Influence Technology Adoption and Increase Reimbursement in Multiple Sites of Care
• Assessment of US Reimbursement Environment for Specialty Pharmaceuticals

See more case studies

Presentations

Driving Value in Dx / Rx
Presented by Joseph Ferrara, President of Boston Healthcare at Q1 Productions' Partnerships in Personalized Medicine Conference, April 12-13 2010, San Mateo, CA

Health Reform and Its Impact on the Medical Device Industry
Presented by Charles Mathews, Director of Boston Healthcare at MassMedic's October 2nd 2009 Health Reform Panel